🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to evaluate the efficacy of ixekizumab do...
Status
Completed
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2015-08
Trial ID
NCT02513550
Treatments Being Tested
This multicenter, randomized, double-blind, active-controlled study aims to...
Status
Active Not Recruiting
Location
Dermatology Hospital of Shandong First Medical University (Shandong Provincial Hospitial of Dermatology)
Start Date
2025-05-27
Trial ID
NCT06945107
Treatments Being Tested
Enstilar in combination with Taltz for plaque psoriasis....
Status
Recruiting
Location
Psoriasis Treatment Center of Central New Jersey
Start Date
2020-04-28
Trial ID
NCT04372277
Treatments Being Tested
The purpose of this study is to compare two different formulations of ixeki...
Status
Completed
Location
Covance Clinical Research Inc
Start Date
2020-02-05
Trial ID
NCT04259346
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of ixekizum...
Status
Completed
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2018-11-09
Trial ID
NCT03573323
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of LY2...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-12
Trial ID
NCT01236118
Treatments Being Tested
The purpose of this phase 2 study is to examine if inhibiting IL-17A activa...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2025-02-20
Trial ID
NCT05309616
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of mul...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-05
Trial ID
NCT01253265
Recently, Interleukin (IL)-17 has been identified as a key driver of chroni...
Status
Completed
Location
Mayo Clinic
Start Date
2017-08-15
Trial ID
NCT03099538
Treatments Being Tested
This study will assess the safety and efficacy of LY2439821 compared to pla...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-11-16
Trial ID
NCT01474512
Treatments Being Tested